Ophthalmic Drugs Market Scope, Product Estimates & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Orthopedic Braces and Supports Market Players And Industry Forecasts Till, 2014 - 2024.

According to the Centers for disease Control and Prevention, in 2015, 30 million US adults were estimated to suffer from osteoarthritis. It is estimated that 54.4 million of the US adults are affected with some form of arthritis. People with arthritis are the major target for orthopedic braces and supports. The second most common form of arthritis is rheumatoid arthritis which cause muscle pain. On the basis of end use, the market is segmented into hospitals, orthopedic clinics, Over-the-Counter (OTC), and other facilities. Orthopedic clinics contributed to the largest market share in 2015, due to reluctance of patients to visit specialty clinics for acute musculoskeletal disorders. Download Free Sample  -  https://www.millioninsights.com/industry-reports/orthopedic-braces-supports-market/request-sample Increase in geriatric population is one of the primary driver for the growth of the market. This population is highly affected by musculoskeletal disorders. According to International O
Read more

Solar Cell Market Trends, Share & Scope, Product Estimates & Strategy Framework To 2014 - 2024.

Image
The decrease in PV prices is projected to explore new opportunities for crystalline silicon modules over the estimated period. In addition, advancements in technology in improving the operating efficiency of thin film solar cells are anticipated to increase its demand in commercial and residential applications. The demand for the solar cell in North America was estimated to be over 20 GW in 2014. High PV installations owing to the rising consumer awareness towards benefits in cost associated with the renewable energy systems in the region is expected to drive market growth. However, lack of incentives and federal subsidy after 2016 is expected to witness a reduction in the installation in residential and commercial segments which is expected to hamper growth. Download Free Sample  -  https://www.millioninsights.com/industry-reports/solar-cell-market/request-sample Competitive Market Share Insights The major players in the solar cell market include First Solar Inc., SunPower Corporation
Read more

Automotive Lubricants Market growth driver analysis 2014 - 2025.

The automotive lubricants industry is segmented on the basis of base oil, product type, and geography. By type of product, the segmentation goes like bio-based oil, semi-synthetic/synthetic oil, and mineral oil. Semi-synthetic/synthetic oil holds the largest market share; thanks to its splendid performance. By base oil, the market spans manual transmission fluid, automatic transmission fluid, and engine oil. By geography, the market constitutes North America, LATAM, Asia Pacific, Europe, and MEA. Download Free Sample  -  https://www.millioninsights.com/industry-reports/automotive-lubricants-market/request-sample Asia Pacific is expected to witness the fastest growth due to increase in consumption of vehicles in economies like India. LATAM is fast catching up due to Brazil witnessing tremendous growth in sales of heavy and light vehicles. The players contributing to the automotive lubricants market include Chevron Corporation, Sinopec Corporation, ExxonMobil Corporation, Royal Dutch She
Read more